Literature DB >> 14634240

The use of Matrigel to facilitate the establishment of human cancer cell lines as xenografts.

Peter Mullen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14634240     DOI： 10.1385/1-59259-406-9:287

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN： 1543-1894


× No keyword cloud information.
  10 in total

1.  MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib.

Authors:  Manik Chahal; Yaoxian Xu; David Lesniak; Kathryn Graham; Konrad Famulski; James G Christensen; Manish Aghi; Amanda Jacques; David Murray; Siham Sabri; Bassam Abdulkarim
Journal:  Neuro Oncol       Date:  2010-02-23       Impact factor: 12.300

2.  The influence of proteasome inhibitor MG132, external radiation, and unlabeled antibody on the tumor uptake and biodistribution of (188)re-labeled anti-E6 C1P5 antibody in cervical cancer in mice.

Authors:  Rébécca Phaeton; Xing Guo Wang; Mark H Einstein; Gary L Goldberg; Arturo Casadevall; Ekaterina Dadachova
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

3.  Establishment and characterization of novel cell lines from sinonasal undifferentiated carcinoma.

Authors:  Yoko Takahashi; Michael E Kupferman; Diana Bell; Tilahun Jiffar; June Goo Lee; Tong-Xin Xie; Ning-Wei Li; Mei Zhao; Mitchell J Frederick; Alexander Gelbard; Jeffrey N Myers; Ehab Y Hanna
Journal:  Clin Cancer Res       Date:  2012-10-02       Impact factor: 12.531

4.  Modified breast cancer model for preclinical immunotherapy studies.

Authors:  Eriko Katsuta; Stephanie C DeMasi; Krista P Terracina; Sarah Spiegel; Giao Q Phan; Harry D Bear; Kazuaki Takabe
Journal:  J Surg Res       Date:  2016-06-08       Impact factor: 2.192

Review 5.  Choosing The Right Animal Model for Renal Cancer Research.

Authors:  Paweł Sobczuk; Anna Brodziak; Mohammed Imran Khan; Stuti Chhabra; Michał Fiedorowicz; Marlena Wełniak-Kamińska; Kamil Synoradzki; Ewa Bartnik; Agnieszka Cudnoch-Jędrzejewska; Anna M Czarnecka
Journal:  Transl Oncol       Date:  2020-02-22       Impact factor: 4.243

6.  Geminin Is Essential for Pluripotent Cell Viability During Teratoma Formation, but Not for Differentiated Cell Viability During Teratoma Expansion.

Authors:  Diane C Adler-Wailes; Joshua A Kramer; Melvin L DePamphilis
Journal:  Stem Cells Dev       Date:  2016-11-07       Impact factor: 3.272

7.  In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts.

Authors:  Maya Sreeranganathan; Saji Uthaman; Bruno Sarmento; Chethampadi Gopi Mohan; In-Kyu Park; Rangasamy Jayakumar
Journal:  Int J Nanomedicine       Date:  2017-09-30

8.  Sphere-Formation Assay: Three-Dimensional in vitro Culturing of Prostate Cancer Stem/Progenitor Sphere-Forming Cells.

Authors:  Hisham F Bahmad; Katia Cheaito; Reda M Chalhoub; Ola Hadadeh; Alissar Monzer; Farah Ballout; Albert El-Hajj; Deborah Mukherji; Yen-Nien Liu; Georges Daoud; Wassim Abou-Kheir
Journal:  Front Oncol       Date:  2018-08-28       Impact factor: 6.244

9.  Radioembolization of Hepatocellular Carcinoma with Built-In Dosimetry: First in vivo Results with Uniformly-Sized, Biodegradable Microspheres Labeled with 188Re.

Authors:  José Carlos De La Vega; Pedro Luis Esquinas; Cristina Rodríguez-Rodríguez; Mehrdad Bokharaei; Igor Moskalev; David Liu; Katayoun Saatchi; Urs O Häfeli
Journal:  Theranostics       Date:  2019-01-25       Impact factor: 11.556

Review 10.  Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer.

Authors:  Giulia Rizzo; Andrea Bertotti; Simonetta Maria Leto; Stefania Vetrano
Journal:  J Exp Clin Cancer Res       Date:  2021-06-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.